Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients

Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients

B cell-depleting therapies such as ocrelizumab (OCR) are highly effective in people with multiple sclerosis (MS). Especially at treatment start and initial infusion, infusion-related reactions (IRR) are a common adverse event. The relevance of acute changes of cell-depleting therapies on peripheral...

Full description

Bibliographic Details
Main Authors: Katja Akgün, Johanna Behrens, Dirk Schriefer, Tjalf Ziemssen
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
ocrelizumab
infusion-related reactions
multiple sclerosis
adverse events
Online Access:https://www.mdpi.com/1422-0067/23/22/13759

Similar Items

Similar Items